Dermatology

>

Latest News

FDA extends review of ruxolitinib cream for pediatric atopic dermatitis | Image credit: Contemporary Pediatrics.
FDA extends review of ruxolitinib cream for pediatric atopic dermatitis

June 20th 2025

The FDA has extended the review of ruxolitinib for atopic dermatitis in children 2 to 11 years to September 2025 to evaluate new CMC data.

John Browning, MD, provides practical skincare reminders ahead of summer season
John Browning, MD, provides practical skincare reminders ahead of summer season

June 20th 2025

John Browning, MD, explains dermatological questions to ask, answer in primary care
John Browning, MD, explains dermatological questions to ask, answer in primary care

June 19th 2025

FDA approves new presentation of ustekinumab-stba biosimilar for plaque psoriasis, psoriatic arthritis | Image Credit: Contemporary Pediatrics
FDA approves new presentation of ustekinumab-stba biosimilar for plaque psoriasis, psoriatic arthritis

June 16th 2025

Weekly review: Clesrovimab for RSV approved, new dupilumab data, and more
Weekly review: Clesrovimab for RSV approved, new dupilumab data, and more

June 13th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.